相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。PD-L1 Expression as a Predictive Biomarker in Cancer Immunotherapy
Sandip Pravin Patel et al.
MOLECULAR CANCER THERAPEUTICS (2015)
Phase 1 Study of Intratumoral Pexa-Vec (JX-594), an Oncolytic and Immunotherapeutic Vaccinia Virus, in Pediatric Cancer Patients
Timothy P. Cripe et al.
MOLECULAR THERAPY (2015)
Checkpoint blockade for cancer therapy: revitalizing a suppressed immune system
Yago Pico de Coana et al.
TRENDS IN MOLECULAR MEDICINE (2015)
Repeated intratumoral administration of ONCOS-102 leads to systemic antitumor CD8+ T-cell response and robust cellular and transcriptional immune activation at tumor site in a patient with ovarian cancer
L. Vassilev et al.
ONCOIMMUNOLOGY (2015)
Transient depletion of specific immune cell populations to improve adenovirus-mediated transgene expression in the liver
Pilar Alzuguren et al.
LIVER INTERNATIONAL (2015)
Increased malignancy of oral squamous cell carcinomas (oscc) is associated with macrophage polarization in regional lymph nodes - an immunohistochemical study
Falk Wehrhan et al.
BMC CANCER (2014)
Tumour-infiltrating lymphocytes predict response to definitive chemoradiotherapy in head and neck cancer
P. Balermpas et al.
BRITISH JOURNAL OF CANCER (2014)
Adenovirus-Based Vaccines for Fighting Infectious Diseases and Cancer: Progress in the Field
Dragomira Majhen et al.
HUMAN GENE THERAPY (2014)
Small oral squamous cell carcinomas with nodal lymphogenic metastasis show increased infiltration of M2 polarized macrophages - An immunohistochemical analysis
Manuel Weber et al.
JOURNAL OF CRANIO-MAXILLOFACIAL SURGERY (2014)
Predicting immunogenic tumour mutations by combining mass spectrometry and exome sequencing
Mahesh Yadav et al.
NATURE (2014)
MPDL3280A (anti-PD-L1) treatment leads to clinical activity in metastatic bladder cancer
Thomas Powles et al.
NATURE (2014)
Predictive correlates of response to the anti-PD-L1 antibody MPDL3280A in cancer patients
Roy S. Herbst et al.
NATURE (2014)
PD-1 blockade induces responses by inhibiting adaptive immune resistance
Paul C. Tumeh et al.
NATURE (2014)
Tolerance and exhaustion: defining mechanisms of T cell dysfunction
Andrea Schietinger et al.
TRENDS IN IMMUNOLOGY (2014)
Immune Cell-Poor Melanomas Benefit from PD-1 Blockade after Targeted Type I IFN Activation
Tobias Bald et al.
CANCER DISCOVERY (2014)
Tumor-infiltrating T-cells: important players in clinical outcome of advanced melanoma patients
Esther P. M. Tjin et al.
ONCOIMMUNOLOGY (2014)
Local treatment of a pleural mesothelioma tumor with ONCOS-102 induces a systemic antitumor CD8+ T-cell response, prominent infiltration of CD8+ lymphocytes and Th1 type polarization
Tuuli Ranki et al.
ONCOIMMUNOLOGY (2014)
Oncolytic viruses as therapeutic cancer vaccines
David L. Bartlett et al.
MOLECULAR CANCER (2013)
Oncolytic Adenovirus With Temozolomide Induces Autophagy and Antitumor Immune Responses in Cancer Patients
Ilkka Liikanen et al.
MOLECULAR THERAPY (2013)
Signatures of mutational processes in human cancer
Ludmil B. Alexandrov et al.
NATURE (2013)
T cell exhaustion: a means or an end?
Shahram Salek-Ardakani et al.
NATURE IMMUNOLOGY (2013)
Safety and Tumor Responses with Lambrolizumab (Anti-PD-1) in Melanoma
Omid Hamid et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Up-Regulation of PD-L1, IDO, and Tregs in the Melanoma Tumor Microenvironment Is Driven by CD8+ T Cells
Stefani Spranger et al.
SCIENCE TRANSLATIONAL MEDICINE (2013)
Antitumor immune responses mediated by dendritic cells How signals derived from dying cancer cells drive antigen cross-presentation
Lotte Spel et al.
ONCOIMMUNOLOGY (2013)
Rewiring cancer cell death to enhance oncolytic viro-immunotherapy
Samuel T. Workenhe et al.
ONCOIMMUNOLOGY (2013)
Plasticity of tumour and immune cells: a source of heterogeneity and a cause for therapy resistance?
Michael Hoelzel et al.
NATURE REVIEWS CANCER (2013)
Regulation of dendritic cell development by GM-CSF: molecular control and implications for immune homeostasis and therapy
Lianne van de Laar et al.
BLOOD (2012)
CD20+ Tumor-Infiltrating Lymphocytes Have an Atypical CD27- Memory Phenotype and Together with CD8+ T Cells Promote Favorable Prognosis in Ovarian Cancer
Julie S. Nielsen et al.
CLINICAL CANCER RESEARCH (2012)
The Immune Score as a New Possible Approach for the Classification of Cancer
Jerome Galon et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2012)
A First in Human Phase 1 Study of CG0070, a GM-CSF Expressing Oncolytic Adenovirus, for the Treatment of Nonmuscle Invasive Bladder Cancer
James M. Burke et al.
JOURNAL OF UROLOGY (2012)
Safety, Activity, and Immune Correlates of Anti-PD-1 Antibody in Cancer
Suzanne L. Topalian et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Colocalization of Inflammatory Response with B7-H1 Expression in Human Melanocytic Lesions Supports an Adaptive Resistance Mechanism of Immune Escape
Janis M. Taube et al.
SCIENCE TRANSLATIONAL MEDICINE (2012)
Tumor-infiltrating B cells and T cells Working together to promote patient survival
Julie S. Nielsen et al.
ONCOIMMUNOLOGY (2012)
Significance of M2-Polarized Tumor-Associated Macrophage in Pancreatic Cancer
Hiroshi Kurahara et al.
JOURNAL OF SURGICAL RESEARCH (2011)
Pharmacological Interventions for Improving Adenovirus Usage in Gene Therapy
Hidde J. Haisma et al.
MOLECULAR PHARMACEUTICS (2011)
Sequential Therapy With JX-594, A Targeted Oncolytic Poxvirus, Followed by Sorafenib in Hepatocellular Carcinoma: Preclinical and Clinical Demonstration of Combination Efficacy
Jeong Heo et al.
MOLECULAR THERAPY (2011)
A Mechanistic Proof-of-concept Clinical Trial With JX-594, a Targeted Multi-mechanistic Oncolytic Poxvirus, in Patients With Metastatic Melanoma
Tae-Ho Hwang et al.
MOLECULAR THERAPY (2011)
Local and Distant Immunity Induced by Intralesional Vaccination with an Oncolytic Herpes Virus Encoding GM-CSF in Patients with Stage IIIc and IV Melanoma
Howard L. Kaufman et al.
ANNALS OF SURGICAL ONCOLOGY (2010)
CD8+ tumor-infiltrating lymphocytes predict favorable prognosis in malignant pleural mesothelioma after resection
Noriyuki Yamada et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2010)
Combining oncolytic virotherapy and tumour vaccination
Byram W. Bridle et al.
CYTOKINE & GROWTH FACTOR REVIEWS (2010)
Treatment of Cancer Patients With a Serotype 5/3 Chimeric Oncolytic Adenovirus Expressing GMCSF
Anniina Koski et al.
MOLECULAR THERAPY (2010)
Viruses as vaccine vectors for infectious diseases and cancer
Simon J. Draper et al.
NATURE REVIEWS MICROBIOLOGY (2010)
Immune infiltration in human tumors: a prognostic factor that should not be ignored
F. Pages et al.
ONCOGENE (2010)
Tumor antigen-specific CD8 T cells infiltrating the tumor express high levels of PD-1 and are functionally impaired
Mojgan Ahmadzadeh et al.
BLOOD (2009)
A phase I trial of intratumoral administration of recombinant oncolytic adenovirus overexpressing HSP70 in advanced solid tumor patients
J-L Li et al.
GENE THERAPY (2009)
The Influence of Innate and Pre-Existing Immunity on Adenovirus Therapy
Anne K. Zaiss et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2009)
Regulatory T cells and the PD-L1/PD-1 pathway mediate immune suppression in malignant human brain tumors
Joannes F. M. Jacobs et al.
NEURO-ONCOLOGY (2009)
Predominant infiltration of macrophages and CD8+ T cells in cancer nests is a significant predictor of survival in stage IV nonsmall cell lung cancer
Osamu Kawai et al.
CANCER (2008)
Immunogenic cancer cell death: a key-lock paradigm
Antoine Tesniere et al.
CURRENT OPINION IN IMMUNOLOGY (2008)
Changing the adenovirus fiber for retaining gene delivery efficacy in the presence of neutralizing antibodies
M. Sarkioja et al.
GENE THERAPY (2008)
Shaping and reshaping CD8+ T-cell memory
John T. Harty et al.
NATURE REVIEWS IMMUNOLOGY (2008)
High number of intraepithelial CD8(+) tumor-infiltrating lymphocytes is associated with the absence of lymph node metastases in patients with large early-stage cervical cancer
Sytse J. Piersma et al.
CANCER RESEARCH (2007)
Adjusting batch effects in microarray expression data using empirical Bayes methods
W. Evan Johnson et al.
BIOSTATISTICS (2007)
Type, density, and location of immune cells within human colorectal tumors predict clinical outcome
Jerom Galon et al.
SCIENCE (2006)
Human CD8+ cytotoxic T cell responses to adenovirus capsid proteins
J Tang et al.
VIROLOGY (2006)
Galectin-3 expression correlates with apoptosis of tumor-associated lymphocytes in human melanoma biopsies
MR Zubieta et al.
AMERICAN JOURNAL OF PATHOLOGY (2006)
Intraepithelial CD8+ tumor-infiltrating lymphocytes and a high CD8+/regulatory T cell ratio are associated with favorable prognosis in ovarian cancer
E Sato et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Effector function of human tumor-specific CD8 T cells in melanoma lesions:: A state of local functional tolerance
A Zippelius et al.
CANCER RESEARCH (2004)
T-cell activation marker expression on tumor-infiltrating lymphocytes as prognostic factor in cutaneous malignant melanoma
A Ladányi et al.
CLINICAL CANCER RESEARCH (2004)
Internal control DNA for PCR assays introduced into lambda phage particles exhibits nuclease resistance
M Stöcher et al.
CLINICAL CHEMISTRY (2004)
A phase I open-label, dose-escalation, multi-institutional trial of injection with an E1B-attenuated adenovirus, ONYX-015, into the peritumoral region of recurrent malignant gliomas, in the adjuvant setting
EA Chiocca et al.
MOLECULAR THERAPY (2004)
Fatal systemic inflammatory response syndrome in a ornithine transcarbamylase deficient patient following adenoviral gene transfer
SE Raper et al.
MOLECULAR GENETICS AND METABOLISM (2003)
Statistical significance for genomewide studies
JD Storey et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Blood clearance rates of adenovirus type 5 in mice
R Alemany et al.
JOURNAL OF GENERAL VIROLOGY (2000)
An adenovirus E1A mutant that demonstrates potent and selective systemic anti-tumoral efficacy
C Heise et al.
NATURE MEDICINE (2000)
分享论文
